Differences between the third cardiac β-adrenoceptor and the colonic β3-adrenoceptor in the rat

British Journal of Pharmacology

Volumn 118, Issue 8, 1996, Pages 2085-2098

  Kaumann, Alberto J ^a,b   Molenaar, Peter ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Antagonists; Non conventional partial agonists; Putative 3 adrenoceptors; Rat atrium and colon; Selective agonists; 3 adrenoceptor

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 3 ADRENERGIC RECEPTOR; BUPRANOLOL; CYANOPINDOLOL; ISOPRENALINE; NORADRENALIN; PARTIAL AGONIST; POTASSIUM CHLORIDE; PROPRANOLOL;

ANIMAL TISSUE; ARTICLE; CHRONOTROPISM; COLON; CONTROLLED STUDY; FEMALE; HEART LEFT ATRIUM; HEART MUSCLE; HEART PAPILLARY MUSCLE; HEART RIGHT ATRIUM; HEART STIMULATION; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SMOOTH MUSCLE RELAXATION;

EID: 0029832673     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15648.x     Document Type: Article

References (39)

1. 3-Adrenoceptors and atypical β-adrenoceptors. Med. Res. Rev., 48, 663-729.
2. ARCH, J.R., AINSWORTH, A.T., CAWTHORNE, M.A., PIERCY, V., SENNITT, M.V. & THODY, V.E. (1984). Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature, 309, 163-165.
3. 3-adrenoceptor mRNA in human tissues. Eur. J. Pharmacol., 289, 223-228.
4. BIANCHETTI, A. & MANARA, L. (1990). In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical β-adrenoceptors in rat colon. Br. J. Pharmacol., 100, 831-839.
5. 2-selective adrenoceptor antagonist (ICI 118,551). J. Cardiovasc. Pharmacol., 5, 430-437.
6. 3-adrenoceptor: structure-activity relationship of β-adrenergic ligands. Mol. Pharmacol., 44, 1094-1104.
7. 3-adrenoceptors. Br. J. Pharmacol., 112, 911-919.
8. 3-selective agonists BRL 37344 and CL 316243 on blood pressure and heart rate in the rat. Drug Dev. Clin. Pract., 7, 37-44.
9. DOLAN, J.A., MUENKEL, H.A., BURNS, M.G., PELLEGRINO, S.M., FRASER, C.M., PIETRI, F., STROSBERG, A.D., LARGIS, E.E., DUTIA, M.D., BLOOM, J.D., BASS, A.S., TANKELLA, T.K., COBUZZI, A., LAI, F.M. & CLAUS, T.H. (1994). Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J. Pharmacol. Exp. Ther., 269, 1000-1006.
10. 3-adrenoceptor. Science, 245, 1118-1121.
11. 3-adrenoceptor mRNA in rat tissues. Br. J. Pharmacol., 117, 210-216.
12. 3-adrenoceptors in human ventricular cells. Circulation, 92, abstract 3065, P 639.
13. 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn-Schmiedeberg's Arch. Pharmacol., 331, 60-70.
14. GRANNEMAN, J.G., LAHNERS, K.N. & CHAUDHRY, A. (1991). Molecular cloning and expression of the rat beta 3-adrenergic receptor. Mol. Pharmacol., 40, 895-899.
15. GRANNEMAN, J.G., LAHNERS, K.N. & CHAUDHRY, A. (1993). Characterization of the human beta 3-adrenergic receptor gene. Mol. Pharmacol., 44, 264-270.
16. KAUMANN, A.J. (1972). Potentiation of the effects of isoprenaline and noradrenaline by hydrocortisone in cat heart muscle. Naunyn-Schmiedeberg's Arch. Pharmacol., 273, 134-153.
17. KAUMANN, A.J. (1973). Adrenergic receptors in heart muscle. Two different mechanisms of β blockers as partial agonists. International Union of Biochemistry, Symposium 52. Acta Physiol. Latamer., 23, 235-236.
18. KAUMANN, A.J. (1983). Cardiac β-adrenoceptors. Experimental viewpoints. Z. Kardiol., 72, 63-82.
19. 2-adrenoceptors activated by (-)-adrenaline in rat sinoatrial mode. Naunyn-Schmiedeberg's Arch. Pharmacol., 332, 406-409.
20. KAUMANN, A.J. (1989). Is there a third heart β-adrenoceptor? Trends Pharmacol. Sci., 10, 316-320.
21. 4-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 619-622.
22. KAUMANN, A.J. (1996). (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br. J. Pharmacol., 117, 93-98.
23. KAUMANN, A.J. & BLINKS, J.R. (1980). β-Adrenoceptor blocking agents as partial agonists in isolated heart muscle. Dissociation of stimulation and blockade. Naunyn-Schmiedeberg's Arch. Pharmacol., 311, 237-248.
24. KAUMANN, A.J., MORRIS, T.H. & BIRNBAUMER, L. (1979). A comparison of the influence of N-isopropyl and N-tert. butyl substituents on the affinity of ligands for sinoatrial β-adrenoceptors in rat atria and β-adrenoceptors coupled to the adenylyl cyclase in kitten ventricle. Naunyn-Schmiedeberg's Arch. Pharmacol., 307, 1-8.
25. 3-adrenergic receptor mRNA in man. J. Clin. Invest., 91, 344-349.
26. LANGUIN, D., PORTILLO, M.P., SAULNIER-BLACHE, J.S. & LAFONTAN, M. (1991). Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol., 199, 291-301.
27. LEMOINE, H. & KAUMANN, A.J. (1982). A novel analysis of concentration-dependence of partial agonism. Ring demethylation of bupranolol results in a high affintiy partial agonist (K 105) for myocardial and tracheal β-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 320, 130-144.
28. LEMOINE, H. & KAUMANN, A.J. (1983). A model for the interaction of competitive antagonists with two receptor-subtypes characterized by a Schild-plot with apparent slope unity. Agonist-dependent enantiomeric affinity ratios for bupranolol in tracheae but not in right atria of guinea pigs. Naunyn-Schmiedeberg's Arch. Pharmacol., 322, 111-120.
29. 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP. Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 56-69.
30. 3-adrenoceptors, mediate the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat. Br. J. Pharmacol., 117, 943-949.
31. 3-selective antagonists, aryloxypropanolaminotetralins. Br. J. Pharmacol., 117, 435-442.
32. 3) β-adrenoceptors. Pharmacol. Comm., 6, 253-258.
33. 3-Adrenoceptors and intestinal motility. Fund. Clin. Pharmacol., 9, 332-342.
34. MARANO, M. & KAUMANN, A.J. (1976). On the statistics of drug-receptor constants for partial agonists. J. Pharmacol. Exp. Ther., 198, 518-525.
35. 3-adrenoceptors) mediating relaxation in the rat distal colon in vitro. Br. J. Pharmacol., 101, 569-574.
36. 2-sites. Br. J. Pharmacol., 82, 897-904.
37. ORIOWO, M.A., SENNITT, M.V., SMITH, S.A., RUFFOLO, R.R. JR. & CAWTHORNE, M.A. (1994). The β-adrenoceptor selectivity profile of BRL 37344 in the pithed rat. J. Autonom. Pharmacol., 14, 337-344.
38. 3-adrenergic receptors. Fund. Clin. Pharmacol., 9, 211-218.
39. WALTER, M., LEMOINE, H. & KAUMANN, A.J. (1984). Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig: role of β-adrenoceptor subtypes in the dissociation between blockade and stimulation. Naunyn-Schmiedeberg's Arch. Pharmacol., 327, 159-175.